Keyphrases
Acute Myocardial Infarction
90%
Alginate
17%
Alginate Scaffold
11%
Angiotensin-converting Enzyme Inhibitor (ACEi)
12%
Aspirin
19%
Bezafibrate
11%
Biomaterials
17%
Cardiac Cells
14%
Cardiac Fibroblasts
12%
Cardiac Function
17%
Cardiac Regeneration
14%
Cardiac Remodeling
18%
Cardiogenic Shock
17%
Cardiomyocyte Transplantation
11%
Cardiomyocytes
11%
Cellular Biology
15%
Clinical Outcomes
11%
Confidence Interval
31%
Coronary Artery Disease
12%
Diabetic
11%
European Society of Cardiology
14%
Extracellular Vesicles
12%
Heart Failure
45%
Infarct
15%
Infarct Repair
16%
Infarcted Heart
12%
Infarcted Myocardium
38%
Infarction
13%
Irreversible Electroporation
12%
Israel
18%
Left Ventricular Dysfunction
15%
Left Ventricular Function
23%
Left Ventricular Remodeling
22%
Macrophages
25%
Myocardial Infarction
100%
Myocardial Injury
14%
Myocardial Regeneration
18%
Myocardial Repair
22%
Myocardium
20%
Odds Ratio
20%
Patients with Coronary Artery Disease
18%
Patients with Heart Failure
23%
Position Paper
15%
Regeneration
13%
Reperfusion
12%
Scar
13%
Thrombolysis
21%
Thrombolytic Therapy
15%
Tissue Engineering
16%
Transplantation
28%
Medicine and Dentistry
Acute Heart Infarction
36%
Alginic Acid
14%
Arteriosclerotic Heart Disease
6%
Bezafibrate
6%
Biocompatible Material
6%
Cardiac Dysrhythmia
8%
Cardiac Muscle Cell
18%
Cardiogenic Shock
10%
Cardiology
15%
Cardiovascular System
16%
Catheterization
6%
Cell Culture
6%
Cell Therapy
13%
Congestive Heart Failure
45%
Cord Blood
6%
Coronary Artery Disease
14%
Diseases
10%
Echocardiography
12%
Ex Vivo
9%
Extracellular Matrix
7%
Fibrinolytic Therapy
9%
Fibroblast
7%
Heart Function
10%
Heart Muscle Injury
10%
Heart Muscle Ischemia
7%
Heart Transplantation
8%
Heart Ventricle Function
10%
Heart Ventricle Remodeling
29%
Heterotopic
6%
In Vitro
9%
Infarction
22%
Interleukin 1
6%
Irreversible Electroporation
6%
Ischemic Heart Disease
11%
Liposome
6%
Macrophage
21%
Magnetic Resonance Imaging
10%
Maturity Onset Diabetes of the Young
11%
Mesenchymal Stem Cell
17%
Myocardial Infarction
72%
Myocarditis
6%
Myocardium
39%
Odds Ratio
11%
Progenitor Cell
9%
Regeneration
17%
Reperfusion Injury
8%
Stem Cell
7%
Stem Cell Therapy
6%
Tissue Regeneration
24%
Toll Like Receptor 4
6%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
16%
Acute Heart Infarction
63%
Alginic Acid
20%
Bezafibrate
11%
Biomaterial
14%
Combination Therapy
9%
Congestive Heart Failure
48%
Coronary Artery Disease
26%
Diabetes Mellitus
12%
Digoxin
9%
Dipeptidyl Carboxypeptidase Inhibitor
12%
Diseases
11%
Doxorubicin
6%
Fibrinolytic Agent
17%
Heart Arrhythmia
12%
Heart Disease
10%
Heart Infarction
83%
Heart Muscle Fibrosis
5%
Heart Muscle Injury
16%
Heart Muscle Ischemia
10%
Heart Ventricle Fibrillation
7%
Heart Ventricle Remodeling
37%
Hexachlorophene
5%
Implant
7%
Infarction
48%
Inferior Myocardial Infarction
6%
Inflammation
12%
Interleukin 1
6%
Ischemia
8%
Ischemic Heart Disease
11%
Liposome
9%
Mitral Valve Regurgitation
6%
Mortality Rate
6%
Myocarditis
7%
Non Insulin Dependent Diabetes Mellitus
14%
Prevalence
10%
Recombinant Erythropoietin
6%
Reperfusion Injury
8%
Scatter Factor
6%
Table Salt
9%